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Background: The American healthcare system spends a large amount of economic and human resources
on fighting acute sepsis. Even with years of research, mortality rates remain high. Reducing mortality
outcomes from sepsis by elucidating biomarkers and the role secondary comorbidities play could assist in
sepsis triage and improve outcomes in septic patients. The purpose of this study is to assess to what degree
one secondary comorbidity, acute kidney failure, contributes to mortality rates among acutely septic patients
in a rural Midwestern hospital located in southwest Missouri.
Methods: Cohort study assessing septic patients with and without acute kidney injuries (AKIs). ICD10
codes were submitted by physicians into Freeman Health System’s Electronic Medical Records and
gathered from January 2019 to June of 2020. Those cases were filtered by secondary diagnosis resulting
in two comparison groups, one sepsis only group and one sepsis with acute kidney failure not otherwise
specified (NOS) group, as defined by ICD10 codes. The data was analyzed for mortality outcomes looking at
secondary diagnosis, age, and sex as variables.
Results: There were 1,122 septic patients in our study, with over 58% having a secondary diagnosis of
acute kidney failure. There was a difference in the average mortality rates between patients with sepsis
(16.59%) vs. those with sepsis and acute kidney failure (25.68%). We found the probable difference in
mortality rate to be significant with a P value =0.003. We are 95% confident that the mortality is between
4.3% and 13.8% higher in acute kidney NOS patients. There was no significant mortality difference found
when sex and aged 65 years and older were included as variables.
Conclusions: Specific to our sample, septic patients with a diagnosis of acute kidney NOS are at a higher
risk of mortality than those without acute kidney NOS, irrespective of age or sex. Our study provides insights
into variables affecting sepsis outcomes in a rural Midwestern population. Further studies are warranted into
individual comorbidities affecting sepsis patient outcomes. Conclusions made here are specific to our sample;
the role of acute kidney failure in the outcomes of septic patients should be further investigated in rural areas
throughout the country.
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Introduction
Sepsis is the number one cost of hospitalization in the
United States (U.S.) accounting for more than $38 billion
annually (1). A recent study found the average hospital wide
cost of each sepsis case to be $32,421 (2). It places a large
financial burden on Medicare, Medicaid and private health
insurance. According to the Sepsis Alliance, a charitable
organization whose commitment is to battle sepsis, sepsis
is the most expensive diagnosis and the primary cause for
hospital readmission within 30 days of visit (3). Increasing
our understanding of sepsis prevention, as well as decreasing
secondary sepsis-associated conditions, will help to decrease
patient mortality and cut national healthcare expenses.
In recent years, a large amount of research has focused
on sepsis pathophysiology, early detection, and common
drug therapies. The approach in this study was to further
understand the most common comorbidity of sepsis, acute
kidney failure, and how it affects septic patient outcomes.
The goal of this study is to guide the focus of physicians
for triaging sepsis patients treated in rural, Midwestern
hospitals.
A plethora of comorbidities associated with sepsis can
negatively affect both short-term and long-term patient
outcomes. Perhaps the most common secondary diagnosis
confronting sepsis patients is acute kidney injury (AKI)
leading to kidney failure. Up to half of all cases of acute
renal failure are associated with sepsis, and up to 60% of
patients with sepsis have AKIs (4). It would be reasonable
to assume that as comorbidities multiply, mortality rates
would increase, especially with complications as severe as
organ failure. Because AKI and renal failure are the most
common comorbidities associated with sepsis, it is essential
to understand to what extent they contribute to increases in
patient mortality. The pathophysiology of the association
between sepsis and AKI has been of recent interest; thus,
it is important to understand the big-picture and how that
relationship could be affecting communities.
Sepsis-associated AKI (SA-AKI) is associated with such a
high mortality rate that it is sometimes used as a “biomarker”
in predicting poor prognosis (5). Even when mortality
is not the outcome, AKI from sepsis can result in longlasting decrease in quality of life and high economic costs.
Sepsis is the dominant cause of AKI in intensive care unit
(ICU) patients, and frequently requires patients to utilize
continuous renal replacement therapy (CRRT), which
improves outcomes but at a large economic and quality of
life burden (6,7). If the damage is severe enough to both
kidneys, sepsis may cause permanent hypoxic damage
© Journal of Emergency and Critical Care Medicine. All rights reserved.
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requiring donor transplantation. The cost for patient
treatment is high, and quality of life is greatly diminished.
Prevention of permanent kidney damage via early sepsis
detection and bundle therapy is the current standard
treatment of care (8). Whether or not this approach is
sufficient in prevention of kidney dysfunction has yet to be
looked at and is currently unknown.
The Midwest has historically suffered from a higherthan-national-average mortality burden from sepsis (9).
In 2016, half of those diagnosed with sepsis were expected
to succumb to their illness (9). While rates of diagnoses
follow national trends, the rate of mortality in Kansas and
Missouri is slightly higher. In some Midwestern areas, the
sepsis mortality rate is suggested to approach 50% (9).
The increased risk of mortality faced by these patients
could be due to a multitude of factors including healthcare
accessibility, education, lifestyle or secondary comorbidities.
In this study, we attempt to quantify to what degree one
common secondary comorbidity, acute kidney failure,
contributes to the local sepsis mortality rate.
While previous studies have investigated kidney
injuries in association with sepsis, it has not been looked
at in rural community hospitals. A large portion of the
American population lives in what is arguably considered
rural communities. It is well established that mortality
rates associated with septic shock are higher in these
communities, and thus merit deeper examination (10).
Rural America faces unique challenges, such as increased
transport time to hospitals and fewer public resources. For
seriously ill patients, this could foreseeably cause postponed
care. Upon arrival to rural hospitals, patients may encounter
fewer resources and in-house specialists. Efficiency in
triaging using biomarkers or secondary comorbidities
has the potential to reduce the mortality rate in septic
patients. AKI could be a critical piece to treating sepsis
efficiently due to required fluid bolus intake. The ability
for physicians to monitor biomarkers associated with worse
sepsis outcomes will facilitate the formation of better triage
protocols to help these severely ill patients. We present the
following article in accordance with the STROBE reporting
checklist (available at https://jeccm.amegroups.com/article/
view/10.21037/jeccm-21-117/rc).
Methods
Data collection
This is a retrospective observational cohort study in which
electronic medical records from Freeman Health System
J Emerg Crit Care Med 2022;6:13 | https://dx.doi.org/10.21037/jeccm-21-117
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Table 1 ICD10 codes used to isolate initial sample group of 1,122 patients
ICD 10 code

Corresponding diagnosis

A400

Sepsis due to Streptococcus, group A

A401

Sepsis due to Streptococcus, group B

A403

Sepsis due to Streptococcus pneumonia

A408

Other Streptococcal sepsis

A409

Streptococcal sepsis, unspecified

A4101

Sepsis due to Methicillin susceptible
Staphylococcus aureus

A4102

Sepsis due to Methicillin resistant
Staphylococcus aureus

A411

Sepsis due to other specified Staphylococcus

A412

Sepsis due to unspecified Staphylococcus

A413

Sepsis due to Haemophilus influenza

A414

Sepsis due to anaerobes

A4150

Gram-negative sepsis, unspecified

A4151

Sepsis due to Escherichia coli

A4152

Sepsis due to Pseudomonas

A4153

Sepsis due to Serratia

A4159

Other Gram-negative sepsis

A4181

Sepsis due to Enterococcus

A4189

Other specified sepsis

A419

Sepsis, unspecified organism

R6520

Severe sepsis without septic shock

R6521

Severe sepsis with septic shock
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Freeman Health System approved this study under the IRB
protocol: The Surviving Sepsis Campaign (SSC) and Its
Effect on Patient Populations with Sepsis and Preexisting
Comorbidities (ethics approval ID: 2021002). Due to its
retrospective nature, consent was not needed.
Statistical analysis
Those cases that fulfilled the diagnostic requirements of
having one of the ICD10 codes listed in Table 1 were kept as
our initial sample group and contained 1,122 patients. The
data was separated further into patients categorized with
ICD10 code N17.9, or having acute kidney failure NOS.
Patients with both sepsis and acute kidney failure NOS
ICD10 codes were one subgroup titled acute kidney NOS,
and those with only sepsis ICD10 codes were the control
subgroup titled non-acute kidney NOS. All provided data
was accounted for. The goal of the analysis was to determine
whether the mortality rate in the acute kidney NOS sample
group is higher than the mortality rate in the non-acute
kidney NOS sample group, or rather those that solely have
sepsis. Mortality rate was defined as the proportion of the
group that expire. The data was statistically analyzed using
two sample proportion summary hypothesis tests. There
was a baseline assumption that both samples were less than
10% of the general population and the dependent variable
of mortality had to have ten or more patients. That data
was considered significant when P<0.05, a 95% confidence
interval (CI) for the proportion difference was also used.
Confounding variables investigated were age and sex.
Results

were analyzed. The data used in the study was gathered
from January 1, 2019 to June 30, 2020. The data was derived
from 1,122 patients admitted to Freeman Health System in
Joplin, Missouri. Patients were selected for using the ICD10
codes listed in Table 1. Diagnostic requirements for sepsis
generally follow CMS guidelines which include: two or
more criteria of systemic inflammatory response syndrome
(SIRS) and a known or suspected infection (11). The data
represents patients from the surrounding areas and city of
Joplin, Missouri; including the states of Arkansas, Kansas
and Oklahoma, arguably considered the rural Midwest. The
study was conducted in accordance with the Declaration
of Helsinki (as revised in 2013). Patient identifiers
were removed in order to maintain patient anonymity
and confidentiality. The Institutional Review Board at

© Journal of Emergency and Critical Care Medicine. All rights reserved.

Our sample included 1,122 patients with sepsis, 658 (58%)
of which also had a diagnosis of acute kidney NOS. The
sample was fairly evenly divided by sex with 574 males and
548 females. A slight majority 595 (53%) of the patients
were above the age of 65.
The mortality rate of sepsis patients with acute kidney
NOS is higher than the mortality rate of the patients
without a diagnosis of acute kidney NOS in our sample.
The probable difference in mortality rate is significant with
a P value =0.003. We are 95% confident that the mortality
is between 4.3% and 13.8% higher in acute kidney NOS
patients (Table 2). It is notable that the difference is spread
relatively evenly between the two sexes, so neither men nor
women are driving the results of the overall sample group
in Table 2. The probable difference in mortality rate for
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Table 2 Comparison of patients with acute kidney NOS to non-acute kidney NOS patients
Difference

Count 1 Total 1 Count 2 Total 2

Sample
difference

Std. err.

Z-stat

P value

L. limit

U. limit

Acute kidney NOS patients to non-acute kidney NOS patients
p1 − p2

169

658

77

464

0.09089063 0.025081369 3.6238305 0.0003* 0.043348825 0.13843244

Males p1 − p2

84

336

39

238

0.086134454 0.033670807 2.4777081 0.0132* 0.020140885 0.15212802

Females p1 − p2

85

322

38

226

0.095833562 0.036205503 2.6469336 0.0081* 0.027310857 0.16435627

Acute kidney NOS patients to non-acute kidney NOS patients including variables: age and age + sex
p1 − p2

117

426

59

268

0.054498634 0.03392105 1.6066317 0.1081

–

–

Age 65 + male p1 − p2

57

216

31

138

0.039251208 0.047099262 0.83337203 0.4046

–

–

Age 65 + females p1 − p2

62

210

28

120

0.07985348 0.049234607 1.6218974 0.1048

–

–

Comparison within male sample groups and female sample groups of patients with acute kidney NOS vs. non-acute kidney NOS.
(*, indicates significant P value). Comparisons of patients with acute kidney NOS vs. non-acute kidney NOS with confounding variables
age and age + sex. Two sample proportion summary hypothesis test with 95% confidence interval results: p1: proportion of successes for
acute kidney NOS sample group; p2: proportion of successes for non-acute kidney NOS sample group; p1 − p2: difference in proportions;
H0: p1 − p2 =0; HA: p1 − p2 ≠0. NOS, not otherwise specified; std. err., standard error; Z-stat, Z-statistic; P value, probability value; L.
limit, lower limit; U. limit, upper limit; H0, null hypothesis; HA, alternative hypothesis.

both males and females with acute kidney NOS was also
significant with P values = males 0.0132 and females 0.0081
(CI: males =2–3.3% and females =2.7–3.4%) (Table 2).
Mortality does not appear to be impacted by the defined age
categories. There were no significant differences detected
in the 65+ age groups (Table 2). Thus, sepsis patients with
acute kidney NOS, specifically in our population, are at a
higher risk of mortality than those without acute kidney
NOS irrespective of age or sex.
Discussion
The mortality rate of sepsis patients with acute kidney NOS
is higher than the mortality rate of the non-acute kidney
NOS patients. We expected this finding because logically
any form of progression to organ failure can indicate
a poor prognosis. Additionally, damage to the delicate
vasculature of the kidney can be irreversible. Historically
it was thought that renal hypoperfusion was responsible
for kidney ischemia and injury (11,12). Blood flow to the
kidney is moderated by a group of cells called the macula
densa which line the distal tubule. When these cells sense
an increase or decrease of chloride ion concentration, they
activate tubuloglomerular feedback to correct renal blood
flow by changing the diameter of the afferent arteriole (13).
It is intuitive that sepsis-induced hypotension can throw this
system out of balance and cause kidney injury. However, it

© Journal of Emergency and Critical Care Medicine. All rights reserved.

is now understood that there are many factors influencing
sepsis-related kidney injury, including microvascular
endothelial dysfunction via inflammation, coagulation,
and oxidative stress (14). Although the causes for SA-AKI
are not fully understood, it is intuitive that damage to a
delicate organ with an important function is associated with
increased mortality.
Monitoring kidney function in septic patients from rural
areas, which are known to have worse outcomes, signifies
a greater emphasis is needed on research in this area. The
data points to the kidney being an especially impactful
organ in the pathophysiology of septic shock as indicated
by the AKI ICD10 diagnostic code listed on the patient’s
electronic medical record (EMR) along with the sepsis
diagnosis. Whether via decreased perfusion or alternative
mechanism, sepsis appears to be inducing AKI in our
sample group which is leading to poorer patient outcomes.
Perhaps less intuitively, there was not a significant
difference in mortality detected in the 65+ age groups
(Table 2). We would expect older patients concurrently
battling sepsis and renal failure to have increased mortality,
but we did not find this to be the case in our sample. One
possibility is that once sepsis has progressed to organ
failure, the condition is so severe that the prognosis is poor
regardless of the age of the patient. We cannot be sure why
mortality in patients age 65+ was not significantly higher
than those under 65, and these results are specific to our

J Emerg Crit Care Med 2022;6:13 | https://dx.doi.org/10.21037/jeccm-21-117
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sample at this point in time.
It is important to note that our study is specific to
our region in Southwestern Missouri. Rural Midwestern
populations have different challenges than more urban
regions of the U.S. Along with Southern states, Midwestern
states have higher rates of obesity than other regions of the
U.S. (15,16). Obesity is thought to be a risk factor for AKI,
with increasing body mass index (BMI) corresponding to
an increased risk of severe disease (17). Diet and exercise
habits contribute to obesity in rural settings. Traditional
weight management programs require further travel for
rural patients, decreasing the accessibility of nutrition
support groups and exercise facilities (18). These challenges
may contribute to generalized poor health, which in turn
contributes to the higher rates of mortality from sepsis in
the Midwest.
Medical interventions that help combat both sepsis
and kidney failure are still under development, and septic
patients who develop kidney failure are at high risk. In 2002,
the SSC was established to increase awareness surrounding
sepsis and decrease associated mortality. In 2004, the
SSC published guidelines for two clinical approaches
in combating sepsis: “resuscitation” and “management”
bundles (19). The bundles are sets of standardized
intervention protocols to be completed during certain
timeframes throughout the progression of sepsis. Although
there is still plenty of room for improvement in bundle
development and compliance protocols, studies show
encouraging results regarding their effectiveness (20,21). A
promising intervention for septic patients with severe renal
failure, CRRT, has also shown beneficial results. Studies
show that patients utilizing CRRT do not show higher
mortality rates than the non-acute kidney NOS group (7,22).
Thus, CRRT is likely a protective therapy for patients with
sepsis-associated kidney injury.
Limitations of the study include a small sample size
that was primarily Caucasian. Samples were also not
randomly selected from the population; consequently, it
is unclear whether or not the samples are representative
of their respective populations as a whole. Although we
cannot generalize our results across the population, we did
show that renal failure is a significant factor in predicting
mortality outcomes specific to our septic patient sample
group. We chose to focus on the most common sepsis
comorbidity that affected the kidney and filter out the rest
such as ICD10 code N17, AKI. This was done to encompass
the largest number of acute kidney + sepsis patients possible
within our sample population, but other more specific

© Journal of Emergency and Critical Care Medicine. All rights reserved.
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kidney and ureter pathologies that could affect septic
patients may have been missed. Socio-economic status,
access to healthcare, education and pre-existing conditions
all impact patient outcomes.
It is important to note that additional comorbidities were
not considered in the study but are likely affecting patient
health and mortality outcomes in our sample. The focus
of the study was mortality which is a categorical variable.
Therefore, a quantitative analysis such as multivariable
regression could not be performed. Sample groups were
insufficient in size to isolate the patients with multiple
comorbidities. To address this in future studies, multicenter
analysis, larger hospitals or combined health care systems
that treat a greater number of patients could be used.
Finally, EMRs collected via sepsis ICD10 codes that also
had ICD10 codes for AKI diagnosis are assumed to have
occurred on that visit. Our data set did not allow us to
define personal history of AKI since records obtained was
from one visit to Freeman Health System, and not their
entire electronic health record (EHR). Thus, we assumed
all patients isolated using ICD10 codes for AKI received
their diagnosis at the time of sepsis diagnosis. The only way
to definitively know would be to refer to the patient charts
or EHRs which at the time of this research was restricted
due to limited access on Hospital Campuses following the
onset of COVID-19.
Conclusions
As one of the most expensive and deadly conditions
plaguing the American healthcare system, sepsis has been a
topic of interest for many years, yet a lack of understanding
of how to reduce septic patient mortalities persists. In this
study, we found that septic patients from Freeman Health
System, located in Joplin, Missouri, with a diagnosis of
acute kidney NOS are at a higher risk of mortality than
those without acute kidney NOS, irrespective of age or sex.
Their risk is between 4.3% and 13.8% higher.
Our study provides insights from a rural Midwestern
population in a time where we, as a medical community, are
searching for variables affecting outcomes in septic patients
across the U.S. Further research investigating secondary
comorbidities and biomarkers in severely ill sepsis
patients is needed. These studies should address which
key comorbidities warrant physician focus in order to save
patient’s lives. Additional knowledge in this area could lead
to improved patient care in all geographical regions, with
focus on reducing rural hospital mortality outcomes closer
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to those found in urban centers.

See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
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